These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9606084)

  • 1. Benchmarking the MCNP code for Monte Carlo modelling of an in vivo neutron activation analysis system.
    Natto SA; Lewis DG; Ryde SJ
    Appl Radiat Isot; 1998; 49(5-6):545-7. PubMed ID: 9606084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo design study of a moderated 252Cf source for in vivo neutron activation analysis of aluminium.
    Lewis DG; Natto SS; Ryde SJ; Evans CJ
    Phys Med Biol; 1997 Apr; 42(4):625-36. PubMed ID: 9127441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurements and calculations of thermal neutron fluence rate and neutron energy spectra resulting from moderation of 252Cf fast neutrons: applications for neutron capture therapy.
    Rivard MJ
    Med Phys; 2000 Aug; 27(8):1761-9. PubMed ID: 10984222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monte Carlo simulation of prompt gamma neutron activation analysis using MCNP code.
    Evans CJ; Ryde SJ; Hancock DA; al-Agel F
    Appl Radiat Isot; 1998; 49(5-6):541-3. PubMed ID: 9569538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of background hydrogen by the Monte Carlo computer code MCNP-4A during measurements of total body nitrogen.
    Ryde SJ; al-Agel FA; Evans CJ; Hancock DA
    Ann N Y Acad Sci; 2000 May; 904():134-9. PubMed ID: 10865725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monte Carlo calculations of thermal neutron capture in gadolinium: a comparison of GEANT4 and MCNP with measurements.
    Enger SA; Munck af Rosenschöld P; Rezaei A; Lundqvist H
    Med Phys; 2006 Feb; 33(2):337-41. PubMed ID: 16532938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monte Carlo modelling of neutron depth dose distributions in optimizing prompt gamma in vivo neutron activation analysis systems.
    Utteridge TD; Ralston AC; Wallace SA; Allen BJ; Beddoe AH
    Appl Radiat Isot; 1994 Jul; 45(7):789-94. PubMed ID: 8061660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined use of FLUKA and MCNP-4A for the Monte Carlo simulation of the dosimetry of 10B neutron capture enhancement of fast neutron irradiations.
    Pignol JP; Cuendet P; Brassart N; Fares G; Colomb F; M'Bake Diop C; Sabattier R; Hachem A; Prevot G
    Med Phys; 1998 Jun; 25(6):885-91. PubMed ID: 9650176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutron dosimetry for a general 252Cf brachytherapy source.
    Rivard MJ
    Med Phys; 2000 Dec; 27(12):2803-15. PubMed ID: 11190964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the safety of a body composition analyser based on the PGNAA method.
    Miri-Hakimabad H; Izadi-Najafabadi R; Vejdani-Noghreiyan A; Panjeh H
    J Radiol Prot; 2007 Dec; 27(4):457-64. PubMed ID: 18268376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shielding design studies for a neutron irradiator system based on a 252Cf source.
    da Silva AX; Crispim VR
    Radiat Prot Dosimetry; 2001; 95(4):333-8. PubMed ID: 11707031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facility optimization to improve activation rate distributions during IVNAA.
    Ebrahimi Khankook A; Rafat Motavalli L; Miri Hakimabad H
    J Radiat Res; 2013 May; 54(3):515-31. PubMed ID: 23386375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of activation rate uniformity in a prompt-gamma rays IVNAA facility.
    Hakimabad HM; Motavalli LR
    J Radiat Res; 2010; 51(2):123-30. PubMed ID: 20197646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benchmark test of transport calculations of gold and nickel activation with implications for neutron kerma at Hiroshima.
    Hoshi M; Hiraoka M; Hayakawa N; Sawada S; Munaka M; Kuramoto A; Oka T; Iwatani K; Shizuma K; Hasai H
    Health Phys; 1992 Nov; 63(5):532-41. PubMed ID: 1399639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation of the possibilities of BNCT treatment planning with the Monte Carlo method.
    Konijnenberg MW; Mijnheer BJ; Raaijmakers CP; Stecher-Rasmussen F; Watkins PR
    Strahlenther Onkol; 1993 Jan; 169(1):25-8. PubMed ID: 8434336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monte Carlo simulations to advance characterisation of landmines by pulsed fast/thermal neutron analysis.
    Maucec M; Rigollet C
    Appl Radiat Isot; 2004 Jul; 61(1):35-42. PubMed ID: 15145436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monte Carlo model of the Studsvik BNCT clinical beam: description and validation.
    Giusti V; Munck af Rosenschöld PM; Sköld K; Montagnini B; Capala J
    Med Phys; 2003 Dec; 30(12):3107-17. PubMed ID: 14713077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new approach to dose estimation and in-phantom figure of merit measurement in BNCT by using artificial neural networks.
    Ahangari R; Afarideh H
    Australas Phys Eng Sci Med; 2011 Dec; 34(4):467-79. PubMed ID: 22042720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of the gamma-ray component from 252Cf fission neutron source--optimization for biological irradiations and comparison with MCNP code.
    Endo S; Stevens DL; Bonner P; Hill MA; Nikjoo H; Dalla Vecchia M; Komatsu K; Hoshi M; Goodhead DT
    Phys Med Biol; 1999 May; 44(5):1207-18. PubMed ID: 10368013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calibration of the delayed-gamma neutron activation facility.
    Ma R; Zhao X; Rarback HM; Yasumura S; Dilmanian FA; Moore RI; Lo Monte AF; Vodopia KA; Liu HB; Economos CD; Nelson ME; Aloia JF; Vaswani AN; Weber DA; Pierson RN; Joel DD
    Med Phys; 1996 Feb; 23(2):273-7. PubMed ID: 8668109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.